Valentina V. Salomashkina

Valentina V. Salomashkina

Auto-generated profile, based on publicly available information

Valentina V. Salomashkina

National Medical Research Center for Hematology

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2017 in Russian Journal of Genetics
Verified
Journal Article
Closed access
PDF file
VSV. V. Salomashkina
V. V. Salomashkina
MKM. V. Kholodova
M. V. Kholodova
USU. A. Semenov
U. A. Semenov
AMA. S. Muradov
A. S. Muradov
AMA. Malkhasyan
A. Malkhasyan
We perform an analysis of the diversity of the control region fragment (570 bp) and ten nuclear microsatellite loci for 36 specimens of the brown bear (Ursus arctos) from several regions of the Caucasus. Four mitochondrial haplogroups that significantly differ from each other are revealed. An assumption of reiterative brown bear colonization of the Caucasus is made. Microsatellite data analysis shows a medium level of heterozygosity and clear differentiation between Caucasian and European bears combined with a slight distinction between the Caucasian regions.

1 January 2016 in Terapevticheskii arkhiv
Verified
Journal Article
Closed access
LGL. L. Golovkina
L. L. Golovkina
ASA. G. Stremoukhova
A. G. Stremoukhova
TPT. D. Pushkina
T. D. Pushkina
RKR. S. Kalandarov
R. S. Kalandarov
GAG. V. Atroshchenko
G. V. Atroshchenko
VSV. G. Savchenko
V. G. Savchenko
The weak D antigen could be serologically identified in 96.8% of cases. When testing for weak D, particular attention should be given to people with the D-negative phenotype who had the C or E antigens. Our investigations conducted for the first time in Russia will be able to improve the immunological safety of red blood cell-containing medium transfusions for patients.

19 January 2023 in Genes
Verified
Journal Article
Open access
PDF file
OPOlesya Pshenichnikova
Olesya Pshenichnikova
VSValentina Salomashkina
Valentina Salomashkina
JPJulia Poznyakova
Julia Poznyakova
DSDaria Selivanova
Daria Selivanova
DCDaria Chernetskaya
Daria Chernetskaya
VSVadim Surin
Vadim Surin
Hemophilia A (HA) is one of the most widespread, X-linked, inherited bleeding disorders, which results from defects in the F8 gene. Nowadays, more than 3500 different pathogenic variants leading to HA have been described. Mutation analysis in HA is essential for accurate genetic counseling of patients and their relatives. We analyzed patients from 273 unrelated families with different forms of HA. The analysis consisted of testing for intron inversion (inv22 and inv1), and then sequencing all functionally important F8 gene fragments. We identified 101 different pathogenic variants in 267 patients, among which 35 variants had never been previously reported in international databases. We found inv22 in 136 cases and inv1 in 12 patients. Large deletions (1–8 exons) were found in 5 patients, and we identified a large insertion in 1 patient. The remaining 113 patients carried point variants involving either single nucleotide or several consecutive nucleotides. We report herein the largest genetic analysis of HA patients issued in Russia.

13 August 2021 in Blood Coagulation & Fibrinolysis
Verified
Journal Article
Closed access
VSValentina V. Salomashkina
Valentina V. Salomashkina
OPOlesya S. Pshenichnikova
Olesya S. Pshenichnikova
FPFarida G. Perina
Farida G. Perina
VSVadim L. Surin
Vadim L. Surin
Hemophilia A is a clotting disease caused by defects in the F8 gene. A lot of them are described and most are unique or have polyphyletic origin. We here study the origin of a pathogenic variant found in a few patients. We sequenced F8 gene for seven hemophilia A patients from the Ural region, Sverdlovskaya oblast, Russia. We constructed haplotypes for them and for 21 hemophilia A patients with other defects from the same area as a control group using four previously described X-chromosome loci associated with F8 gene. We identified a new missense variant p.(His634Arg) in seven apparently unrelated patients with mild hemophilia A from Sverdlovskaya oblast. The haplotype analysis showed that all patients share the same haplotype, absent in the other patients, suggesting a founder effect. The most recent common ancestor for the p.(His634Arg) patients is estimated to exist around the end of XVII century; however, the 95% confidence interval spans from XII to early XX century. The Ural region did not suffer from the recent bottlenecks or isolation. Therefore, the founder effect could be a natural consequence of population structuring in a relatively stable population. We identified a founder effect mutation in hemophilia A, which is a quite rare event for this disease.

26 June 2018 in Russian Journal of Genetics
Verified
Journal Article
Closed access
PDF file
VSV. L. Surin
V. L. Surin
VSV. V. Salomashkina
V. V. Salomashkina
OPOlesya Pshenichnikova
Olesya Pshenichnikova
FPF. G. Perina
F. G. Perina
OBO. N. Bobrova
O. N. Bobrova
Nadezhda ZozulyaNadezhda Zozulya
Nadezhda Zozulya
Hemophilia A is a recessive X-linked hereditary disease, so its manifestation in women is extremely rare and can be a result of an asymmetric X-chromosome inactivation or, even more rarely, of a...

6 July 2022 in Russian journal of hematology and transfusiology
Verified
Journal Article
Open access
PDF file
EYE. V. Yakovleva
E. V. Yakovleva
VSV. V. Salomashkina
V. V. Salomashkina
VSV. L. Surin
V. L. Surin
DSD. S. Selivanova
D. S. Selivanova
PLPolina Lavrova
Polina Lavrova
Nadezhda ZozulyaNadezhda Zozulya
Nadezhda Zozulya
Introduction. In most cases, in patients with hereditary fibrinogen deficiency, clinical manifestations are represented by bleeding of varying intensity and localization. However, the clinical picture of hereditary fibrinogen deficiency can also be represented by thrombosis.Aim — to characterize the detected mutations in fibrinogen genes and to analyze prothrombotic factors in patients with hereditary hypofibrinogenemia and thrombosis.Materials and methods. Forty-nine patients with hereditary hypofibrinogenemia were observed, of which 46 patients had no history of thrombosis and 3 patients had a confirmed history of thrombosis. These 3 patients made up the study group.Results. Heterozygous mutations were found in all 3 patients in the fibrinogen gamma chain gene (FGG), one of them had a previously undescribed deletion g.2653_2684+211del, p.(Asp167Glufs*2), which removes 32 terminal nucleotides of the fifth exon of the FGG gene and leads to the formation of a stop codon in place of amino acid 168. In two other patients, there were missense mutations c.1140T>A, p.(Cys365Ser) and c.1114A>T, p.(Asp356Val), which can determine the thrombogenic properties of the altered protein structure of fibrinogen. Other prothrombotic factors were also identified: genetic polymorphisms of low thrombotic risk, surgery, taking combined oral contraceptives.Conclusion. Hereditary fibrinogen deficiency does not play a protective role in relation to the development of thrombosis and may cause the development of thrombosis, which is associated with its multifunctional role in the hemostasis system. The pathogenesis of thrombosis in patients with hereditary hypofibrinogenemia is multifactorial and may be associated with the characteristics of the main protein defect and the coexistence of hereditary and acquired thrombotic risk factors (surgical interventions, taking combined oral contraceptives, etc.).